Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT04243655
What this trial is testing

Use of HA 330-II for Hemofiltration in Patients With ALF as a Bridge to Liver Transplantation .

Who this might be right for
Acute-On-Chronic Liver Failure
Asian Institute of Gastroenterology, India 10
Testing effectiveness (Phase 2)Study completedNCT06247735
What this trial is testing

Study to Evaluate the Efficacy and Safety of K-808 (Pemafibrate) in Participants With Primary Biliary Cholangitis (PBC) With Inadequate Response to Ursodeoxycholic Acid (UDCA) and/or Obeticholic Acid (OCA) Treatment.

Who this might be right for
Primary Biliary Cholangitis
Kowa Research Institute, Inc. 46
Testing effectiveness (Phase 2)UnknownNCT03732547
What this trial is testing

Study of PolyIC and PD-1 mAb in Subjects With Unresectable Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Second Affiliated Hospital, Zhejiang University, School of Medicine 60
Not applicableUnknownNCT06325826
What this trial is testing

The Study of the Validation of General Evaluation Score (GES) in the Prediction of Hepatocellular Carcinoma Risk Among Patients With Advanced Fibrosis and Cirrhosis Who Achieved Sustained Virological Response for Hepatitis C Virus After Direct Acting Antiviral Drugs

Who this might be right for
Hepatocellular Carcinoma
Egyptian Liver Hospital 500
Not applicableUnknownNCT05968378
What this trial is testing

Diet, Immunometabolism and Non-alcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseLiver FatObesity+1 more
University College Dublin 60
Not applicableNot Yet RecruitingNCT07584317
What this trial is testing

AI-Based Multimodal Integration for Tumor Microenvironment Analysis and Response Prediction in HCC Treated With TACE Plus Immunotherapy and Targeted Therapy (CHANCE2601)

Who this might be right for
Hepatocellular Carcinoma
Gao-jun Teng 1,170
Large-scale testing (Phase 3)Study completedNCT02604017
What this trial is testing

Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Subjects With Genotype 1 Infection

Who this might be right for
Chronic Hepatitis CHepatitis C VirusHCV
AbbVie 703
Testing effectiveness (Phase 2)Ended earlyNCT05517668
What this trial is testing

Evaluation of the Efficacy of Fomepizole in the Treatment of Acetaminophen Overdose

Who this might be right for
AcetaminophenDrug OverdoseAcetaminophen Overdose+4 more
Richard Dart, MD, PhD 29
Not applicableNot Yet RecruitingNCT06708650
What this trial is testing

Combination of SFRT, PD-L1 Inhibitor, and Anti-VEGF in Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaRadiotherapyPD-1 Inhibitors
Guiping People's Hospital 50
Not applicableStudy completedNCT04891874
What this trial is testing

Adjuvant Radiotherapy for Resected Hepatocellular Carcinoma With MVI

Who this might be right for
Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 76
Not applicableStudy completedNCT01767597
What this trial is testing

Application of HBV Rapid Tests as a Tool for Wide-Use Screening

Who this might be right for
Hepatitis BLiver CirrhosisCarcinoma, Hepatocellular
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba 1,000
Early research (Phase 1)Study completedNCT02496897
What this trial is testing

Phase I Safety and Immunogenicity of FP-02.2 in Chronic Hepatitis B

Who this might be right for
Hepatitis B
Altimmune, Inc. 61
Testing effectiveness (Phase 2)Study completedNCT02471313
What this trial is testing

Integrated Imaging Strategy to Phenotype Progression of Liver Tumors During and After Chemoembolization

Who this might be right for
Liver CancerLiver NeoplasmHepatocellular Carcinoma+1 more
National Institutes of Health Clinical Center (CC) 3
Not applicableNot Yet RecruitingNCT05451082
What this trial is testing

Registry-based Study in Patients With Hepatitis D Virus (HDV) Infection in China

Who this might be right for
Hepatitis D
Lai Wei 1,000
Not applicableNot Yet RecruitingNCT06446908
What this trial is testing

Acceptability and Feasibility of a New Approach to Engage Patients With Steatotic Liver Disease in Physical Activity

Who this might be right for
Liver SteatosisMASHMASLD
Hopital Montfort 12
Very early researchUnknownNCT04048317
What this trial is testing

Effectiveness of Drug Eluting TACE in Primary HCC

Who this might be right for
Hepatic Cell Carcinoma
Assiut University 75
Early research (Phase 1)UnknownNCT04104074
What this trial is testing

Safety and Efficacy of Radiotherapy Plus Sintilimab for HCC With Portal Vein Tumor Thrombosis

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor Thrombosis
Beijing Tsinghua Chang Gung Hospital 20
Early research (Phase 1)Study completedNCT01114490
What this trial is testing

Pharmacokinetics of Anacetrapib (MK0859) in Patients With Hepatic Insufficiency (MK-0859-039)

Who this might be right for
Dyslipidemia
Merck Sharp & Dohme LLC 24
Testing effectiveness (Phase 2)Study completedNCT04264260
What this trial is testing

Evaluation the Palliative Effects of Colchicine on Primary Hepatic Malignant Tumors Unable to Receive Curative Treatment

Who this might be right for
Hepatocellular Carcinoma Stage IIIBCholangiocarcinoma, IntrahepaticCholangiocarcinoma; With Hepatocellular Carcinoma+1 more
Kaohsiung Medical University Chung-Ho Memorial Hospital 42
Testing effectiveness (Phase 2)Study completedNCT01188733
What this trial is testing

Efficacy of Long-acting Octreotide (Sandostatin LAR) in Reducing Portal Pressure in Patients With Cirrhosis

Who this might be right for
CirrhosisPortal HypertensionEsophageal Varices
Mayo Clinic 39
Next Page